Recursion to Participate in Upcoming Investor Conference
- Tuesday, August 2, 2022, 7:00
- Finance
- Add a comment
SALT LAKE CITY, Aug. 2, 2022 /PRNewswire/ — Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following investor conference: KeyBanc Technology Leadership Forum — August 8…
About the Author
adminasapcorp has written 39120 stories on this site.